Precision Health: Molecular Basis, Technology and Digital Health

Overview

Conference Overview

This conference addresses the promises and challenges of precision health, the molecular insights necessary to enable a maintenance of wellness and prevention of disease and the new technologies needed to apply those insights in the clinic. There has been a leap in our molecular understanding of disease and disease risk, yet our application of these insights to disease prevention and monitoring is still rudimentary. This conference will assemble leading basic and clinical researchers to share and discuss the latest systems-wide data in different areas and is the continuation of the highly successful EMBL-Stanford Personalised Health series that offers an unusually rich opportunity to hear from, and interact with, leaders in the field on the efforts towards molecular approaches to personalised health.

Session Topics

• Molecular basis of health and disease
• Big data and genotype to disease predictions
• Clinical, ethical and societal issues
• Precision medicine in practice
• Wearables and technology
• Disease models

Speakers

Keynote Speakers

Edith Heard

EMBL Heidelberg

Germany

Hiromitsu Nakauchi

Stanford University School of Medicine

USA

Speakers

Ruedi Aebersold

ETH Zürich

Switzerland

Patrick Aloy

Institute for Research in Biomedicine

Spain

Ami Bhatt

Stanford University

USA

Ewan Birney

EMBL-EBI

UK

Christoph Bock

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences

Austria

Christina Curtis

Stanford University

USA

Emmanouil Dermitzakis

University of Geneva Medical School

Switzerland

Emma Farley

University of California, San Diego

USA

Martin Fussenegger

ETH Zurich

Switzerland

Julien Gagneur

Technical University of Munich

Germany

Andreas Hierlemann

ETH Zürich

Switzerland

Leroy Hood

Institute for Systems Biology

USA

Wolfgang Huber

EMBL Heidelberg

Germany

Olli Kallioniemi

Science for Life Laboratory, Karolinska Institutet

Sweden

Emma Lundberg

Science for Life Laboratory, KTH Royal Institute of Technology

Sweden

Benjamin Meder

University Hospital Heidelberg

Germany

Christoph Merten

EMBL Heidelberg

Germany

Caroline Pabst

University Hospital Heidelberg

Germany

Barbara Prainsack

University of Vienna

Austria

Stephen Quake

Stanford University

USA

Angela Rogers

Stanford University

USA

Eran Segal

Weizmann Institute of Science

Israel

Oliver Stegle

EMBL Heidelberg and German Cancer Research Center

Germany

Gosia Trynka

Wellcome Sanger Institute

UK

Christof von Kalle

Berlin Institute of Health – Charité Clinical Study Center

Germany

David Walt

Wyss Institute at Harvard University, Harvard Medical School, Brigham and Women’s Hospital

USA

Scientific Organisers

Michael Snyder

Stanford University

USA

Lars Steinmetz

EMBL Heidelberg

Germany

Judith Zaugg

EMBL Heidelberg

Germany

Conference Organisers

Lisa Trinh

EMBL Heidelberg

Germany

Programme